CNNC International Limited Overview
CNNC International is the sole Hong Kong-listed, offshore uranium platform of China National Nuclear Corporation, China's state-owned nuclear champion. The company is, in substance, an asset-light natural uranium (U3O8) trading house rather than a miner: in FY2025 it sold approximately 8.77 million pounds of natural uranium and generated HK$2.49bn of revenue, essentially all from its "Trading of Mineral Properties" segment. Its commercial moat is structural rather than technological — under successive framework agreements with its intermediate parent CNUC, it acts as the exclusive offshore supplier of non-Asian, non-African uranium to the CNUC Group, as the CNUC Group's procurement agent, and as exclusive ex-China distributor for the Rössing mine in Namibia. Legacy upstream assets (a 37.2% stake in Niger's idle Azelik/Somina mine and an exploration project in Mongolia with expired licences) are written down. With HK$733m of cash, no borrowings and 39 staff, it is a cash-rich, thin-margin, policy-anchored trading vehicle whose earnings are highly sensitive to spot-market volatility and parent-group delivery schedules.
Company's own description (latest filings)
The company describes itself (H1 2026 interim results, "Business Overview") as continuing "its business of trading uranium products in its normal and usual course of business", focusing on and developing its uranium products trading business while "actively seeking high-quality uranium resources projects to complement the development of the Parent Group". Its stated strategic pursuit is to become the CNUC Group's major platform for overseas uranium resources exploration, development and trading, and to be "designated as the procurement arm of the CNUC Group in the international uranium market" (H1 2026 interim, Future Strategies).
The two reportable segments under HKFRS 8 are:
Trading of mineral properties: trading of uranium and commission income from uranium procurement services;
Exploration and selling of mineral properties: exploration and selling of uranium (currently pre-revenue; legacy Mongolia project).
Business model
CNNC International makes money in three ways, all within the trading segment:
-
Principal trading (gross revenue recognition). The group buys natural uranium (U3O8) from producers, traders and inventory holders — principal suppliers are located in the United States, Europe/Canada, Kazakhstan and Hong Kong (Morningstar/extraETF company descriptions) — and on-sells it either to (a) independent third parties (utilities, traders, financial buyers) or (b) the CNNC Parent Group under the "Uranium Supply Transaction" continuing connected transaction (CCT). The group takes price and basis risk on these trades and earns the spread.
-
Agency procurement (net commission). Under the "Uranium Agency Transaction", the group procures uranium in the market to meet sporadic CNUC Group demand and earns a commission recognised on a net basis.
-
Distribution for Rössing (net commission). Under the "Uranium Purchase Transaction", the group acts as exclusive authorised distributor for uranium produced by the Rössing Uranium Mine in Namibia (68.62% indirectly owned by the CNUC Group) for on-sale to customers outside the PRC, earning commissions without assuming pricing risk.
Revenue mix (derived from FY2024 Final Results Note 3 and Gelonghui FY2025 coverage):
FY2025 commission income = HK$30.994m (Uranium Purchase Transaction / Rössing) + HK$13.657m (Uranium Agency Transaction) per Gelonghui's summary of the FY2025 results; principal trading derived as the residual. In product/service terms the mix is ~98% product sales, ~2% service/commission; there is no subscription or licensing revenue.
Value-chain position
The company sits in the mid-stream "physical market intermediary" link of the nuclear fuel cycle: between uranium miners (Kazatomprom, Cameco, Orano, Rössing) and the conversion/enrichment/fuel-fabrication chain whose ultimate customers are nuclear utilities. Material is typically transferred by book-transfer at conversion facilities (FY2024 MD&A references storage fees at "designated natural uranium conversion facilities"). The company does not convert, enrich or fabricate fuel, and has no producing mine.
Customer types and end-markets
Parent Group (CNNC/CNUC): the anchor customer for supply and agency transactions — destined for China's nuclear fleet (60 commercial units, 63.69 GW in operation, per the China Nuclear Energy Development Report 2026 as cited in the H1 2026 interim).
Independent third parties: international utilities and traders in the UK, Netherlands, Japan, the US and Canada (FY2023–FY2025 geographic disclosures).
Rössing Uranium Limited: a related-party principal for whom the company distributes ex-China.
Independent characterisation
CNNC International is best characterised as a captive, state-backed uranium trading desk wrapped in a listed shell. Its earnings power is a function of (i) the volume of CCT business allocated by its parent (delivery schedules are back-half weighted — H1 2026 interim), (ii) management's appetite for third-party spot risk (curtailed sharply in H1 2026), and (iii) interest income on a large cash balance. Gross margins (10.9% in FY2025) are high for a pure trading business — sector peer CGN Mining's trading arm earned a 1.0% group gross margin in FY2025 — reflecting opportunistic spot positioning in 2023–2025 rather than structural pricing power. Legacy upstream assets contribute nothing and carry residual political/legal risk.
Strategy
Stated strategy (themes from FY2024 annual results and H1 2026 interim, "Future Strategies")
-
Focus resources on uranium products trading, while actively seeking high-quality uranium resources projects "with intended focus on in-production projects" to complement the Parent Group.
-
Leverage the Parent Group as a "strategic alliance that produces synergistic effects", cementing the group's position in uranium trading.
-
Become the CNUC Group's major overseas platform in uranium exploration, development and trading, and its designated international procurement arm.
-
Enlarge business scale by participating in international market bidding, increasing market exposure, exploring financing channels and developing new trading counterparties.
-
Resolve legacy assets: Mongolian licence expiry dispute; Somina restart plan with the Nigerien government and co-shareholders.
-
Long-term diversification leveraging CNNC's nuclear strengths "to develop projects with reasonable returns", subject to financial health and market dynamics.
Initiatives in the last 24 months (Oct 2024 – Oct 2026)
| Date | Initiative | Detail | Source |
|---|---|---|---|
| Oct–Nov 2024 | Non-core disposal | Sale of CNNC International (HK) incl. 7.55% CNNC Leasing to CNNCTM for HK$162.4m to reduce exposure to non-strategic sectors and redeploy into uranium | FY2024 final results |
| Jul 2024 / Aug 2025 | Parent funding line | US$50m revolving facility from CNNCTM (Jul 2024); Aug 2025 announcement of up to US$50m for the uranium trading business | FY2024 final results; MarketScreener (21 Aug 2025) |
| 31 Dec 2025 – 10 Mar 2026 | 2026 Framework Agreement with CNUC | Renews exclusive supplier, agent and exclusive ex-PRC Rössing distributor roles; caps for FY2026–FY2027 approved by independent shareholders | H1 2026 interim |
| Q1–Q2 2026 | Risk-management pivot | Reduced third-party spot trading; emphasis on no-price-risk Rössing distribution | H1 2026 interim |
| H1 2026 | ESG consultancy | Professional ESG consultation cited as a driver of higher admin costs | H1 2026 interim |
| 24 Jun 2026 | New bank facility | Up to US$30m uncommitted general banking facility for purchasing natural uranium; each drawdown repayable within 180 days; conditions precedent satisfied (announced 3 Jul 2026, including a Rule 13.18 specific-performance-covenant disclosure) | Hstong/company announcement; ETNet |
| H1 2026 | Manpower expansion | Headcount 34 → 39 | H1 2026 interim |
Medium-term targets / guidance
FY2026 volume target: "not less than approximately four million pounds" in H2 2026 and full-year uranium trading volume "targeted at least approximately five million pounds" (H1 2026 interim). This is the only quantitative guidance.
- No medium-term revenue, margin, ROE or dividend targets are published. No cost programme with targets has been disclosed.
Products & Services
The company's "portfolio" is narrow; each line is catalogued below.
Trading of mineral properties segment
(a) Natural uranium (U3O8) — principal sales to the Parent Group ("Uranium Supply Transaction")
Description: Exclusive supply to the CNUC Group of natural uranium purchased from sellers other than those based in Asia and Africa (2024 and 2026 Framework Agreements).
Specifications: Natural uranium concentrate (U3O8), delivered by book transfer; volumes: 3.32m lb in FY2024; ~720 lb in H1 2026 (deliveries scheduled mainly in H2 2026).
Target customer: CNUC Group (for China's reactor fleet).
Latest version: 2026 Framework Agreement (approved 10 Mar 2026; caps for FY2026–FY2027).
Pricing: Market-referenced; annual caps approved by independent shareholders (cap values n/d in sources reviewed).
(b) Natural uranium — principal sales to independent third parties
Description: Spot and term trades with utilities, traders and financial participants internationally.
Volumes: ~0.20m lb in FY2024 (as reported) and in H1 2026; the majority of H1 2025 revenue (~HK$582m of HK$592m) came from third-party natural uranium sales.
Target customers: Counterparties in PRC/HK, UK, Netherlands, Japan, US, Canada.
Pricing: Market (spot/term), group bears price risk.
(c) Uranium Agency Transaction — procurement agency for CNUC Group (commission)
Description: Acts as agent to source uranium in the market for sporadic CNUC demand.
Volumes/economics: 0.75m lb in FY2024 (commission ~HK$5.8m); FY2025 commission ~HK$13.7m; H1 2026 ~230 lb.
Pricing: Commission, recognised net.
(d) Uranium Purchase Transaction — exclusive ex-PRC distributor for Rössing Uranium Mine (commission)
Description: Exclusive authorised distributor of Rössing (Namibia) output for on-sale to third parties worldwide except the PRC; no pricing risk assumed.
Volumes/economics: 1.50m lb facilitated in FY2024 (commission ~HK$18.8m); FY2025 commission ~HK$31.0m; H1 2026 0.56m lb facilitated.
Pricing: Commission.
Exploration and selling of mineral properties segment
(e) Mongolian uranium exploration project (originally Western Prospector's Gurvanbulag project)
Description: Uranium project in eastern Mongolia; Gurvanbulag had M&I resources of 4.28 Mt at 0.189% U3O8 plus 0.795 Mt inferred at 0.126% (Western Prospector estimate cited by Northern Miner, 2009).
Status: Exploration licences expired; company in discussion with Mongolian authorities "to resolve the expiry issue" (H1 2026 interim). Carrying value of exploration and evaluation assets: nil since FY2019 impairment.
(f) Somina / Azelik mine, Niger (associate, 37.2%)
Description: Uranium mine operated by Somina; "still facing serious cash flow problems and is unable to resume production in the short term" (H1 2026 interim); the group is discussing a preliminary restart plan with other shareholders and the Nigerien government.
Status: No production; no equity income.
Discontinued/historical lines (for completeness)
-
Electronics products trading (LCDs, flash drives, memory cards) — commenced 2018, last trade 2020; inventory write-down of ~HK$52m in FY2020 triggered the 2021–2022 audit investigation.
-
Investment in CNNC Financial Leasing (7.55%) — disposed November 2024.
-
Some data vendors also list "electricity transmission services" in the company description; no such revenue appears in FY2022–H1 2026 filings (not corroborated).
Financial Narrative
Sources: ETNet financial summary (FY2022–H1 2026), FY2024/FY2023/FY2022 Final Results announcements, FY2022 profit alert (FY2021 continuing revenue and gross profit), FY2020 unaudited results, H1 2026 interim, Gelonghui (FY2025 cash flow, volumes), TipRanks (FY2021–FY2022 cash flow). FY2021 revenue and gross profit are for continuing operations.
Income statement: notes and sources
Notes: FY2021 cost of sales derived as revenue less gross profit (continuing). FY2021–FY2022 EPS derived (net profit ÷ 489.168m shares). Operating income is not presented as a line item under the company's HKFRS income statement format; EBITDA is derived only where finance costs and D&A are disclosed (FY2023: finance 14.044, D&A 0.270; FY2024: finance 21.729, D&A 1.784). FY2024 EBITDA includes the HK$23.4m disposal gain and HK$32.0m associate share; "core" FY2024 EBITDA excluding these ≈ HK$194.7m (derived).
Margins and growth (derived)
Revenue CAGR FY2021–FY2025 (derived): ~72.6% (HK$280.6m → HK$2,489.9m). Revenue CAGR FY2022–FY2025: ~40.1%. FY2020 revenue was ~HK$663m and FY2019 ~HK$3.17bn (TipRanks), so the long-run series is distorted by the exited electronics business.
Balance sheet
Sources: FY2022 final results (FY2021–FY2022 totals, net assets, associates, net current assets); FY2023 and FY2024 final results; H1 2026 interim (31 Dec 2025 comparatives). FY2021–FY2022 cash from TipRanks "end cash position". Total liabilities derived as total assets less net assets.
H1 2026 snapshot (30 Jun 2026): total assets HK$981.2m; cash HK$732.6m; trade receivables HK$201.3m (0–30 days); amount due from immediate holding company HK$37.0m; total liabilities HK$106.7m; no borrowings; equity HK$874.5m; gearing (total liabilities/total assets) 0.11.
Cash flow: notes and sources
Sources: TipRanks (FY2021–FY2022 OCF/FCF), FY2024 final results (FY2023–FY2024 OCF, capex, net cash inflow), Gelonghui summary of FY2025 results (OCF ~HK$288m, +105.7%). FY2024 net cash inflow included HK$161.7m disposal proceeds and HK$115.2m repayment of a fellow-subsidiary balance. H1 2026 net cash outflow was HK$175.0m (cash used in uranium trading / working capital), vs inflow of HK$179.1m in H1 2025.
Ratios (derived unless stated)
FY2023 and FY2024 ROE of 23.1% and 28.9% match the company's own disclosure (FY2024 MD&A). ROIC: with no interest-bearing debt in FY2024–FY2025 and most capital held as cash, ROIC on operating invested capital (equity less cash) is not meaningful (FY2025 operating invested capital ≈ HK$-38m, derived). Net debt/EBITDA: net cash in FY2024–FY2025. Cash conversion cycle: not computable reliably — trade receivables and payables are both on 5–30 day terms and inventory is negligible at most period-ends (FY2023 was an exception with HK$290m of uranium inventory).
Commentary on trends, inflections and drivers
FY2021 — trough after strategic exit. With the electronics business abandoned and the shares suspended, FY2021 continuing revenue fell to HK$280.6m with a gross profit of only HK$20.6m; net profit of HK$2.4m was rescued by associate income (CNNC Leasing). This is the base from which the uranium-trading rebuild started.
FY2022 — the CNUC framework inflection. Revenue tripled to HK$905.7m and gross profit to HK$102.8m. The FY2022 profit alert attributes the increase to higher trading volume driven by an improving uranium market, upward price momentum and the execution of uranium trading transactions with China National Uranium Corporation under the 2022 framework (circular of 31 May 2022). Net profit reached HK$80.8m, of which HK$25.1m came from associates.
FY2023 — margin peak on spot spike. Revenue fell 35.9% to HK$581.0m, yet gross profit rose to HK$127.1m and gross margin to 21.9%, as the group benefited from the H2 2023 influx of financial buyers into the spot market (FY2024 MD&A). Finance costs of HK$14.0m reflected higher rates on trade financing. Uranium inventory of HK$290m was held at year-end, financed by trade payables of HK$304m.
FY2024 — volume and balance-sheet reset. Revenue rose 217% to HK$1.84bn on 5.77m lb (including facilitated volumes), as the group cleared the Parent Group's backlog carried over from 2023. Gross margin normalised to 12.7% because the 2023 spot-buyer windfall did not recur. Profit of HK$195.0m included two non-recurring items (HK$23.4m disposal gain, HK$32.0m associate share); management's own "core" uranium-trading profit was ~HK$140m (FY2025 profit alert). The CNNC Leasing disposal transformed the balance sheet: the HK$182m parent loan was extinguished and cash rose to HK$607m.
FY2025 — record scale, quality improvement. Revenue reached HK$2.49bn (+35.2%) on ~8.77m lb sold; gross profit rose 16.0% to HK$271.6m with gross margin at 10.9%. Reported net profit (HK$192.4m) was flat, but core trading profit rose ~38% versus the HK$140m FY2024 core figure. Operating cash flow more than doubled to ~HK$288m and year-end cash reached HK$907m with zero borrowings. Notable mix shift: UK and Netherlands customers contributed HK$342m and HK$306m respectively.
H1 2026 — deliberate de-risking. Revenue collapsed 76% to HK$142.1m as the board judged spot trading "overly burdensome" amid a Q1 2026 spike above US$101/lb and Middle East conflict; the group pivoted to riskless Rössing distribution. Net profit fell to HK$5.3m but was supported by HK$13.4m of bank interest income — interest now exceeds gross profit, underscoring the cash-rich, low-utilisation nature of the balance sheet. Management targets ≥4m lb in H2 2026 and ≥5m lb for FY2026 (vs ~8.77m lb in FY2025), implying a materially lower FY2026 revenue base.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment Overview
| Segment | Contents | Products/services |
|---|---|---|
Trading of mineral properties | Physical uranium trading desk (Hong Kong/PRC) | U3O8 principal sales to Parent Group and third parties; commission income from Uranium Agency and Uranium Purchase (Rössing) transactions |
Exploration and selling of mineral properties | Mongolian uranium exploration project (licences expired/disputed); historically Somina-related activities | No revenue; carrying costs only |
Segment revenue (HKD Mn)
| Segment revenue (HKD Mn) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Trading of mineral properties | 581.0 | 1,841.3 | 2,489.9 |
Exploration and selling of mineral properties | 0 | 0 | 0 |
Total | 581.0 | 1,841.3 | 2,489.9 |
Segment profit (HKD Mn)
| Segment profit (HKD Mn) | FY2023 | FY2024 |
|---|---|---|
Trading of mineral properties — segment profit | 116.6 | 209.3 |
Exploration and selling — segment loss | -6.0 | -6.2 |
Total segment profit | 110.6 | 203.1 |
Segment Margins & Growth (%) and Revenue by Segment (%)
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Trading segment profit margin (%) | 20.1 | 11.4 | — |
Trading segment revenue growth YoY (%) | -35.9 | 217.0 | 35.2 |
Trading segment share of revenue (%) | 100 | 100 | 100 |
Segment Assets & Liabilities
| Segment balance sheet (HKD Mn) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Trading segment assets | 514.7 | 630.7 | 964.9 |
Exploration segment assets | 6.0 | 3.5 | 9.0 |
Trading segment liabilities | 310.3 | 179.2 | 98.8 |
Exploration segment liabilities | 22.3 | 19.6 | 21.6 |
Income Statement and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue (HKD Mn) | 280.6 | 905.7 | 581.0 | 1,841.3 | 2,489.9 |
Cost of sales (HKD Mn) | 260.0 | 802.9 | 453.9 | 1,607.2 | 2,218.4 |
Gross profit (HKD Mn) | 20.6 | 102.8 | 127.1 | 234.2 | 271.6 |
Share of results of associates (HKD Mn) | — | 25.1 | 32.2 | 32.0 | 0 |
Gain on disposal (HKD Mn) | — | 0 | 2.4 | 23.4 | 0 |
Finance costs (HKD Mn) | — | — | 14.0 | 21.7 | — |
Profit before tax (HKD Mn) | — | 88.1 | 123.1 | 226.6 | 229.9 |
Income tax (HKD Mn) | — | 7.2 | 16.8 | 31.6 | 37.5 |
Net profit attributable (HKD Mn) | 2.4 | 80.8 | 106.3 | 195.0 | 192.4 |
EBITDA — PBT + finance costs + D&A (HKD Mn) | — | — | 137.4 | 250.1 | — |
Basic & diluted EPS (HK cents) | 0.49 | 16.53 | 21.7 | 39.9 | 39.3 |
Dividend per share (HK cents) | 0 | 0 | 0 | 0 | 0 |
Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Gross margin (%) | 7.3 | 11.3 | 21.9 | 12.7 | 10.9 |
Pre-tax margin (%) | — | 9.7 | 21.2 | 12.3 | 9.2 |
EBITDA margin (%) | — | — | 23.7 | 13.6 | — |
Net margin (%) | 0.9 | 8.9 | 18.3 | 10.6 | 7.7 |
Revenue growth YoY (%) | -57.7 | 222.7 | -35.9 | 217.0 | 35.2 |
Effective tax rate (%) | — | 8.2 | 13.6 | 13.9 | 16.3 |
Balance Sheet
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Total assets (HKD Mn) | 592.7 | 646.9 | 990.9 | 880.1 | 996.8 |
Cash and cash equivalents (HKD Mn) | 120.6 | 130.7 | 180.4 | 607.0 | 907.1 |
Interests in associates (HKD Mn) | 456.1 | 438.3 | 412.7 | 0 | 0 |
Inventories (HKD Mn) | — | — | 291.7 | 1.3 | 0.9 |
Total liabilities (HKD Mn) | 258.0 | 255.3 | 530.6 | 206.2 | 128.3 |
Interest-bearing debt — loan from immediate holding co. (HKD Mn) | — | — | 182.0 | 0 | 0 |
Short-term bank borrowings at year-end (HKD Mn) | — | — | — | 0 | 0 |
Net debt (HKD Mn; negative = net cash) | — | — | 1.6 | -607.0 | -907.1 |
Shareholders' equity (HKD Mn) | 334.7 | 391.6 | 460.3 | 673.9 | 868.5 |
Goodwill & intangibles incl. E&E assets (HKD Mn) | 0 | 0 | 0 | 0 | 0 |
Net current assets / working capital (HKD Mn) | 96.2 | 135.0 | 226.6 | 670.5 | 864.8 |
Cash Flow
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Operating cash flow (HKD Mn) | 31.0 | 7.5 | 73.4 | 140.0 | 288.0 |
Capex — PP&E (HKD Mn) | — | — | 0.4 | 0.6 | — |
Free cash flow (HKD Mn) | 30.7 | 7.3 | 72.9 | 139.3 | — |
Dividends paid (HKD Mn) | 0 | 0 | 0 | 0 | 0 |
Share buybacks (HKD Mn) | 0 | 0 | 0 | 0 | 0 |
Net change in cash (HKD Mn) | — | — | 51.0 | 427.6 | — |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
ROE on closing equity (%) | 0.7 | 20.6 | 23.1 | 28.9 | 22.2 |
ROA on closing assets (%) | 0.4 | 12.5 | 10.7 | 22.2 | 19.3 |
Current ratio (x) | — | — | 1.66 | 4.28 | 7.77 |
Total liabilities / equity (x) | 0.77 | 0.65 | 1.15 | 0.31 | 0.15 |
Gearing — total liabilities / total assets (x, company definition) | 0.44 | 0.39 | 0.54 | 0.23 | 0.13 |
Interest coverage — (PBT + finance costs) / finance costs (x) | — | — | 9.8 | 11.4 | — |
Asset turnover — revenue / average total assets (x) | — | 1.46 | 0.71 | 1.97 | 2.65 |
OCF / net profit (x) | 12.96 | 0.09 | 0.69 | 0.72 | 1.50 |
Revenue by Region
| Region (HKD Mn) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
PRC incl. Hong Kong | 455.2 | 1,704.6 | 1,769.0 |
United Kingdom | 84.3 | 5.3 | 342.0 |
Netherlands | 0 | 3.1 | 306.0 |
Japan | 1.7 | 63.1 | — |
United States | 39.7 | 62.5 | — |
Canada | 0 | 2.7 | — |
Other / not separately identified in sources reviewed | 0 | 0 | 72.9 |
Total | 581.0 | 1,841.3 | 2,489.9 |
Revenue by Region (%) and Region Margins & Growth (%)
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
PRC share of revenue (%) | 78.3 | 92.6 | 71.0 |
Non-PRC share of revenue (%) | 21.7 | 7.4 | 29.0 |
PRC revenue growth YoY (%) | — | 274.5 | 3.8 |
Non-PRC revenue growth YoY (%) | — | 7.9 | 427.6 |
Share Price History
| Date | Price (HKD) | Source |
|---|---|---|
4 Nov 2024 | 1.80 (52-week range then 0.86–2.63) | Google Finance |
3 Jun 2026 | 4.71 close (intraday high 4.95) | Securities Star via Hstong |
18 Jun 2026 | 3.94 | Fintel / Histock |
6 Jul 2026 | 4.32 | ETNet |
9 Jul 2026 | 4.05 | Securities Star via Hstong |
17 Jul 2026 | 3.76 | Histock |
19 Aug 2026 | ~4.16 (implied from CCASS market value ÷ shares) | Lixinger |
Valuation Snapshot
| Multiple | Value | Basis |
|---|---|---|
Market capitalisation | ~HK$2.03bn | 489.17m × HK$4.16 |
Enterprise value | ~HK$1.30bn | Mkt cap − cash HK$732.6m (30 Jun 2026), no debt |
P/E — FY2025 | ~10.6x | EPS HK$0.393 |
P/E — trailing 12m to Jun 2026 | ~10.9x | TTM EPS HK$0.3826 (39.3 − 2.12 + 1.08 cents) |
P/B | ~2.33x | Equity HK$874.5m (30 Jun 2026) |
EV/Sales — FY2025 | ~0.52x | Revenue HK$2,489.9m |
EV/Sales — TTM | ~0.64x | TTM revenue HK$2,039.9m |
Dividend yield | 0% | No dividends |
Capital Markets
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Dividend per share (HK cents) | 0 | 0 | 0 | 0 | 0 |
Payout ratio (%) | 0 | 0 | 0 | 0 | 0 |
Analyst Conclusions
Management guidance
-
FY2026 uranium trading volume of at least ~5m lb, with ≥4m lb in H2 2026; Parent Group Uranium Supply deliveries primarily scheduled in H2 2026 (H1 2026 interim).
-
Management expects to increase third-party trading in H2 2026 as spot prices "have somewhat stabilized".
-
No revenue, profit or dividend guidance.
Consensus
No sell-side consensus estimates are available. On management's volume target, FY2026 volume would be ~43% below FY2025's ~8.77m lb, implying a materially lower revenue and profit year unless margins or mix improve markedly (analyst inference, not guidance).
Bull case
-
Structural mandate + rising LT prices: exclusive CNUC supply and Rössing distribution through FY2027 coincide with LT uranium at ~US$95/lb, a 2008-level high, and China's 112-unit/125 GW pipeline.
-
Cash optionality: HK$733m net cash is ~36% of market cap; deployment into an in-production asset, a buyback or an inaugural dividend could re-rate the stock.
-
Demonstrated core-earnings growth: FY2025 core trading profit rose ~38% to ~HK$190m with OCF of ~HK$288m at ~10.6x P/E.
Bear case
-
Earnings are episodic: H1 2026 net profit of HK$5.3m shows that when spot volatility rises, management withdraws and earnings collapse; FY2026 volume target is ~5m lb vs 8.77m lb.
-
Capital is trapped: zero dividends for five-plus years despite record cash; minority shareholders bear controlling-shareholder conflict with no payout.
-
Mandate concentration and policy risk: volumes depend on parent allocations, framework renewals (next by end-2027) and US–China trade measures (Section 232).
Catalysts and monitorables (next 12 months)
-
H2 2026 delivery execution vs the ≥4m lb target; FY2026 profit alert (expected ~Feb 2027) and FY2026 results (~Mar 2027).
-
Use of the US$30m bank facility and CNNCTM line (signals third-party trading appetite).
-
Any dividend declaration or buyback under the AGM mandate.
-
Spot/LT uranium prices, SPUT purchasing, US Section 232 tariff decisions.
-
Mongolia licence resolution and Somina restart plan.
-
Any acquisition of an in-production uranium asset.
-
Board changes following Wu Ge's re-designation; framework cap utilisation disclosures in the 2026 annual report.
Analyst verdict
CNNC International has completed a genuine transformation since its 2021–2022 suspension: it shed the failed electronics business and the CNNC Leasing stake, extinguished parent debt, and rebuilt a profitable uranium trading franchise anchored by shareholder-approved exclusivity with CNUC and Rössing. The FY2025 numbers — HK$2.49bn of revenue, ~HK$190m of core trading profit, ~HK$288m of operating cash flow and HK$907m of year-end cash against zero debt — describe a clean, cash-generative business trading at roughly 10–11x earnings and about 0.5x EV/Sales.
The difficulty is that this is a policy-shaped trading desk, not a compounding asset. Its volumes are set by the parent's procurement calendar and by management's tolerance for spot risk, which proved low when prices spiked in Q1 2026; H1 2026 profit fell to HK$5.3m, and bank interest now rivals gross profit. Management's FY2026 target of ~5m lb, well below 2025's ~8.77m lb, points to a year of lower earnings. Legacy upstream assets in Mongolia and Niger carry option value only, and the market has learned to ascribe little to it after more than a decade without resolution.
The investment case therefore rests less on operating momentum than on capital allocation. With cash equal to roughly a third of market capitalisation and a P/B of ~2.3x, the single most value-accretive step available to the board is to establish a payout policy or deploy cash into a producing asset at a sensible price; neither has been signalled. Until it is, the shares are likely to trade as a sentiment proxy for the uranium price with an earnings base that the parent can expand or contract at will. We would characterise the risk/reward as balanced with a negative near-term earnings skew: constructive on the medium-term uranium cycle and the durability of the CNUC mandate, cautious on FY2026 earnings and minority-shareholder returns. Key watchpoints: H2 volumes, capital return, and framework renewal beyond 2027.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Tenure / notes | Committees | Source |
|---|---|---|---|---|
Li Feng (李峰) | Chairman, Non-executive Director | Appointed 1 Dec 2025, succeeding Wang Cheng | Chair, Nomination | H1 2026 interim; MarketScreener |
Zhang Yi (張義) | Executive Director & CEO | CEO since at least March 2021; born 1984 (S&P data) | Remuneration, Nomination | Board notices 2021–2026; Yahoo Finance |
Wu Ge (吳戈) | Executive Director | On board since at least 2021 as NED; re-designated executive director 6 Aug 2026 and left Audit Committee | Remuneration | H1 2026 interim |
Sun Ruofan (孫若凡) | Non-executive Director | On board since at least March 2024 | — | Board notices |
Cui Liguo (崔利國) | Independent NED | On board since at least 2021 | Chair, Remuneration; Audit; Nomination | H1 2026 interim |
Chan Yee Hoi (陳以海) | Independent NED | On board since at least 2021 | Chair, Audit; Remuneration; Nomination | H1 2026 interim |
Liu Yajie (劉亞潔) | Independent NED | Joined 2024 (replacing Zhang Lei) | Audit; Remuneration; Nomination | Board notices 2024–2025 |
Directors' Remuneration
| Item (HKD K) | FY2023 | FY2024 |
|---|---|---|
Directors' emoluments (total) | 1,880 | 2,457 |
Total staff costs (incl. directors) | 20,511 | 29,359 |
Board & Management Changes
| Date | Change |
|---|---|
2023 (by Mar 2023) | Wang Cheng replaces Zhong Jie as chairman |
2023–2024 | Sun Ruofan joins as NED; Liu Yajie replaces Zhang Lei as INED |
3 Dec 2024 | Company secretary changed (Li Philip Sau Yan → Xu Ling) |
1 Dec 2025 | Wang Cheng retires; Li Feng appointed chairman, NED and Nomination Committee chair |
6 Aug 2026 | Wu Ge re-designated from NED to executive director; ceases Audit Committee membership |
Shareholding by CCASS Participant
| CCASS participant (custodian) | Shares (m) | % of issued |
|---|---|---|
CCB International Securities (holds the parent block) | 326.0 | 66.73 |
UOB Kay Hian (Hong Kong) | 47.7 | 9.76 |
HSBC (Hongkong and Shanghai Banking Corp) | 19.3 | 3.96 |
Hang Seng Bank | 7.5 | 1.54 |
Hang Seng Securities | 7.4 | 1.52 |
Bank of China (Hong Kong) | 7.3 | 1.49 |
Competitive Landscape
Key Competitors
| Competitor | Type | Relevance to CNNC International | Positioning |
|---|---|---|---|
CGN Mining (1164.HK) | HK-listed uranium trader/producer (China General Nuclear) | Closest listed peer: offshore uranium platform of China's #2 nuclear group | Larger revenue (HK$6.87bn FY2025), equity production via Semizbay-U and Ortalyk (Kazakhstan); thinner trading margins |
China National Uranium Corp (CNUC) | Sister company | Handles Asia/Africa-sourced supply directly; defines CNNC Intl's mandate boundary | Captive partner more than competitor |
Kazatomprom | World's largest producer; sells directly and via trading subsidiaries | Competes for utility offtake; major supplier | Low-cost ISL producer; sulfuric-acid constraints |
Cameco | Producer/trader (Canada) | Competes for Western utility contracts; trades in spot | 21.0m lb attributable production in FY2025 |
Orano | Producer/fuel-cycle (France) | Competes in supply; lost Niger assets 2024 | Integrated fuel cycle |
Sprott Physical Uranium Trust (SPUT) | Financial buyer | Competes for spot material; price setter in spot | ~2,000 tU purchased in Q1 2026 |
Yellow Cake plc | Financial holder | Competes for spot/term material | Holds physical U3O8 |
Uranium Royalty Corp | Royalty/physical holder | Physical trading counterparty/competitor | Small physical book |
Independent commodity traders (e.g. Traxys, Curzon Resources) | Private traders | Direct competitors in intermediation | Financials not public |
SPIC / other Chinese utilities' procurement arms | State buyers | Compete for imported material on behalf of other Chinese fleets | Financials not segmented |
Peer Comparison FY2025
| Metric | CNNC International | CGN Mining | Cameco | Kazatomprom |
|---|---|---|---|---|
Revenue | HK$2.49bn (+35.2%) | HK$6.87bn (−20.3%) | n/d in sources reviewed | n/d in sources reviewed |
Gross margin | 10.9% | 1.0% | — | — |
Net margin | 7.7% | 6.6% | — | — |
Net profit attributable | HK$192.4m | HK$452.8m | — | — |
Volume | ~8.77m lb sold (incl. facilitated) | 3,315 tU sold by CGN Global (~8.6m lb, derived at 2,600 lb/tU) | 21.0m lb attributable production | Production up YoY; ~10% cut planned for 2026 |
Equity production | — | 855 tU (Semizbay-U, Ortalyk share) | 21.0m lb | Largest globally |
R&D intensity | 0% | — | — | — |
Dividend | Nil | HK1.4 cents total FY2025 | — | — |



